Crinetics Pharmaceuticals Ownership | Who Owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Ownership Summary
Crinetics Pharmaceuticals is owned by 114.08% institutional investors, 1.87% insiders. Blackrock is the largest institutional shareholder, holding 8.62% of CRNX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.92% of its assets in Crinetics Pharmaceuticals shares.
CRNX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Crinetics Pharmaceuticals | 114.08% | 1.87% | -15.95% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 6.23M | 8.62% | $279.06M |
| Driehaus capital management | 6.11M | 8.46% | $273.76M |
| Wellington management group llp | 4.62M | 6.39% | $206.95M |
| Vanguard group | 4.51M | 6.25% | $202.20M |
| Price t rowe associates inc /md/ | 4.41M | 6.10% | $197.37M |
| Ecor1 capital | 4.16M | 5.75% | $186.12M |
| Fmr | 4.10M | 5.67% | $183.50M |
| State street | 2.81M | 3.89% | $125.99M |
| Point72 asset management | 2.78M | 3.85% | $124.55M |
| Jennison associates | 2.78M | 3.85% | $124.52M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Saturn v capital management | 479.68K | 8.12% | $21.48M |
| New leaf venture partners | 141.00K | 7.68% | $6.32M |
| Ecor1 capital | 4.16M | 5.69% | $186.12M |
| Acuta capital partners | 135.14K | 5.10% | $6.05M |
| First light asset management | 1.20M | 4.71% | $53.77M |
| Paradigm biocapital advisors lp | 2.51M | 4.31% | $112.57M |
| Bioimpact capital | 557.18K | 3.88% | $24.96M |
| Cormorant asset management, lp | 1.35M | 3.49% | $60.47M |
| Ghost tree capital | 240.00K | 3.37% | $10.75M |
| First turn management | 369.30K | 2.69% | $16.54M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 4.62M | 0.04% | 1.65M |
| Vanguard group | 4.51M | 0.00% | 939.40K |
| Driehaus capital management | 6.11M | 2.64% | 885.88K |
| Blackrock | 6.23M | 0.01% | 794.27K |
| Price t rowe associates inc /md/ | 4.41M | 0.02% | 583.24K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 2.78M | 0.33% | -2.17M |
| T. rowe price investment management | 1.35M | 0.04% | -1.31M |
| Paradigm biocapital advisors lp | 2.51M | 4.31% | -611.45K |
| First light asset management | 1.20M | 4.71% | -489.67K |
| State street | 2.81M | 0.01% | -442.33K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hood river capital management | 410.34K | 0.38% | 410.34K | $18.38M |
| First turn management | 369.30K | 2.69% | 369.30K | $16.54M |
| Maplelane capital | 160.00K | 0.25% | 160.00K | $7.17M |
| Senator investment group lp | 135.00K | 0.29% | 135.00K | $6.05M |
| Man group | 125.71K | 0.01% | 125.71K | $5.63M |
Sold Out
| Holder | Change |
|---|---|
| Householder group estate & retirement specialist | -25.00 |
| Newedge advisors | -30.00 |
| Massmutual trust co fsb/adv | -34.00 |
| Innealta capital | -36.00 |
| Ashton thomas private wealth | -80.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 239 | 8.64% | 82,467,822 | 2.56% | 114 | 0.92% | 153 | 20.47% | 54 | -3.57% |
| Mar 31, 2024 | 220 | 11.68% | 80,408,468 | 13.80% | 111 | 0.75% | 127 | 13.39% | 56 | - |
| Dec 31, 2023 | 197 | - | 70,656,199 | 3.13% | 121 | 0.84% | 112 | -16.42% | 56 | 86.67% |
| Sep 30, 2023 | 197 | 39.72% | 68,511,935 | 26.84% | 120 | 1.22% | 134 | 63.41% | 30 | -9.09% |
| Jun 30, 2023 | 141 | 10.16% | 54,012,554 | -1.84% | 99 | 0.96% | 82 | 6.49% | 33 | 13.79% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.70M | 2.92% | 293.74K |
| US Small-Cap Growth II Equity Comp | 2.02M | 2.52% | 298.47K |
| T. Rowe Price New Horizons | 2.02M | 2.52% | -6.37K |
| iShares Russell 2000 ETF | 2.26M | 2.50% | -5.07K |
| T. Rowe Price Health Sciences | 1.08M | 1.35% | 19.26K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.20M | 1.33% | 138.44K |
| SPDR® S&P Biotech ETF | 1.07M | 1.19% | 11.88K |
| Vanguard Small Cap Index | 1.07M | 1.16% | 119.71K |
| Fidelity Select Biotechnology | 1.02M | 1.14% | -29.10K |
| Bridge Builder Small/Mid Cap Growth | 997.15K | 1.11% | 7.92K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 03, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $785.31K |
| Sep 26, 2024 | Wilson Marc | CFO | Sell | $1.28M |
| Sep 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | $53.30K |
| Aug 26, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | $159.57K |
| Aug 12, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | $143.04K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 10 |
| 2024 Q2 | - | 11 |
| 2024 Q1 | - | 14 |
| 2023 Q4 | - | 8 |
| 2023 Q3 | - | 3 |
CRNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools